阿托品滴眼液用于儿童近视防控的伦理探究

Ethical Inquiry into the Use of Atropine Eye Drops in Myopia Control in Children

为了解阿托品滴眼液应用于儿童近视防控的现状及可能面临的伦理问题,采用基于扎根理论的质性研究,对福建三甲医院的11位眼科医生进行半结构式访谈。归纳出三个主题,低浓度阿托品滴眼液应用于儿童近视防控的受益与风险,用药前的医患沟通以及应用缺陷。受访者普遍认为低浓度阿托品滴眼液控制近视效果良好、不良反应轻。但阿托品滴眼液的使用存在不确定性,缺乏充足的临床试验数据,且涉及未成年人的健康安全以及医学伦理存在缺陷。建议从临床用药规范和近视防控重要意义的双重角度考虑近视防控方案,保障近视儿童患者安全。

To gain insight into the current application status of atropine eye drops in the prevention and control of myopia,as well as potential ethical issues in pediatric patients,this study employed qualitative research utilizing root theory to conduct semi-structured interviews with 11 ophthalmologists in Fujian.Three core themes emerged:the benefits and risks of low-concentration atropine eye drops in the prevention and control of myopia in children,doctor-patient communication prior to medication administration,and identified application shortcomings.Participants generally held the view that low-concentration atropine eye drops effectively controlled myopia with minimal side effects.Nevertheless,uncertainties surrounding the use of atropine eye drops,lack of comprehensive clinical trial data,and concerns over the safety of minors and medical ethics remain.It is recommended that future myopia prevention and control strategies take into account the dual focus on clinical medication regulation and the significant importance of myopia prevention and control to ensure the safety of myopic children.